What is Carwild?
Established in 1978, Carwild has cultivated a robust reputation for the manufacturing of specialized medical equipment and supplies. Operating from its headquarters in New London, CT, the company serves as a critical node in the medical device ecosystem. By maintaining a focus on high-quality production standards, Carwild has successfully transitioned from a legacy manufacturer to a sophisticated partner for healthcare providers, leveraging its deep industry expertise to maintain a competitive edge in a highly regulated market environment.
How much funding has Carwild raised?
Carwild has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Carwild
PPP
Public-Private Partnership
What's next for Carwild?
With this recent capital injection, Carwild is positioned to accelerate its operational scaling and infrastructure modernization. The strategic allocation of these funds will likely focus on enhancing manufacturing throughput and integrating advanced supply chain technologies to meet the evolving demands of the global healthcare sector. As the company moves into this next phase of growth, the focus will remain on maintaining its core manufacturing excellence while exploring new avenues for market expansion and product diversification, ensuring long-term sustainability in an increasingly digitized medical landscape.
See full Carwild company page
